• Home>
  • Stocks>
  • Novelix Pharmaceuticals Ltd Share Price
Novelix Pharmaceuticals Ltd share price logo

Novelix Pharmaceuticals Ltd Share Price (536565)

₹41.474.99%

as on

| Source : BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Novelix Pharmaceuticals Ltd Stock Performance

as on August 20, 2025 at 4:01 PM IST

  • Day's Low

    ₹39.1
    ₹41.47
    downward going graph

    5.71%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹20.87
    ₹52.79
    downward going graph

    49.67%

    Downside

    27.30%

    Upside

    downward going graph
Previous Close₹39.50
Open₹41.40
Volume13.57K
Upper Circuit₹41.47
Lower Circuit₹37.53
Day's Low39.1
Day's High41.47
52 Week Low20.87
52 Week High52.79
1 Month Return-11.65 %
3 Month Return+ 41.37 %
1 Year Return+ 89.27 %
3 Year Return+ 419.74 %
5 Year Return+ 1035.06 %

Novelix Pharmaceuticals Ltd Stock Fundamentals & Key Indicators

Check Novelix Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹98.55 Cr

Return on Equity (ROE)

-0.24

PE Ratio (TTM)

-14.42

Return on capital employed (ROCE)

-0.24

Industry PE ratio

43.53

Beta (LTM)

0.4

P/B Ratio

1.89

Dividend Yield

0

PEG Ratio

-10.6

Quarterly Earnings Growth YOY

-142.86

EPS (TTM)

-2.5

Sector

Pharmaceuticals

Book Value

9.14

Technical Analysis

Novelix Pharmaceuticals Ltd Stock's Interest Amongst Investors

-30%

Period Aug 21, 2025 to Jul 22, 2025. Change in 30 Days vs previous period

Search interest for Novelix Pharmaceuticals Ltd Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.

Novelix Pharmaceuticals Ltd Stock Valuation

Track how Novelix Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.

Novelix Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-38.24x)

January 31, 2018

Today (-14.42x)

August 19, 2025

Industry (43.53x)

August 19, 2025

Highest (-1.18x)

September 29, 2021

LowHigh

Today’s Price to Earnings Ratio: -14.42x

Novelix Pharmaceuticals Ltd Financial Results

Get the annual and quarterly financial summary of Novelix Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ2 FY22Q3 FY22Q4 FY22Q1 FY23Q2 FY23
Revenue

(in ₹ Cr)

2 (0%)1 (55%)1 (38%)1 (97%)1 (9%)
Net Income

(in ₹ Cr)

0 (0%)-1 (311%)-2 (112%)-0 (94%)-0 (67%)
Net Profit Margin14.23% (0%)-66.67% (569%)-227.54% (241%)-6.62% (97%)-12.10% (83%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

10 (0%)9 (9%)7 (17%)7 (2%)
Total Liabilities

(in ₹ Cr)

3 (0%)1 (51%)0 (96%)0 (67%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

1 (0%)1 (52%)1 (2%)-2 (508%)-0 (86%)

Novelix Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Novelix Pharmaceuticals Ltd.

  • Novelix Pharmaceuticals Ltd Earnings Results

    Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Novelix Pharmaceuticals Ltd Dividends July,2012

    In the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 1.47%.

    Read More about Dividends

Novelix Pharmaceuticals Ltd Stock Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Novelix Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
52.75%
-20.75
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
47.25%
41.31
Others
0%
0.00

Novelix Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Novelix Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA98.55207.01%0.00-38
BUY8,013.9610.61%0.723,5974,565
NA45.19-16.85%0.00-22104
NA714.3563.1%0.5813154
NA46.9919.79%0.50167

Insights on Novelix Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, Novelix Pharma. stock has moved up by 41.4%

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 33.44% to 47.25% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 66.56% to 52.75% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter

About Novelix Pharmaceuticals Ltd

Trimurthi Drugs & Pharmaceuticals Ltd was established in December 1994 and initially engaged in finance and investments. However, due to the volatile market conditions they stopped their operations and carried out diversification into pharmaceuticals and drugs. In 2009 the company was awarded NSEN ISO 9001:2008/ ISO 9001:2008 for marketing and distribution of pharmaceutical products. During 2011 Trimurthi Drugs & Pharmaceuticals Ltd opened their first Pharmacy Retail Outlet in Himayath Nagar and a second retail outlet in Inderbagh Sultan Bazar, Hyderabad. Over the coming years the company plans to expand their business all over India by setting up a marketing network. The company also hopes to open 50 more retail outlets and commence with Pharmacy and Medical Malls based in Hyderabad and Secunderabad providing medical services and products.

Revenue: ₹1.24Cr as on September 2022 (Q2 FY23)
Net Profit: ₹0.15Cr as on September 2022 (Q2 FY23)
OrganisationNovelix Pharmaceuticals Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Novelix Pharmaceuticals Ltd share price today?

Novelix Pharmaceuticals Ltd share price today stands at ₹41.47, Open: ₹41.4, Previous Close: ₹39.5, High: ₹41.47, Low: ₹39.1, 52 Week High: ₹52.79, 52 Week Low: ₹20.87 as on .

How to buy Novelix Pharmaceuticals Ltd shares ?

To buy Novelix Pharmaceuticals Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 536565 or Novelix Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Novelix Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is today's traded volume of Novelix Pharmaceuticals Ltd?

Today's traded volume of Novelix Pharmaceuticals Ltd is 13.57K. Which means that 13.57K shares of Novelix Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.

What is Novelix Pharmaceuticals Ltd's market cap today?

Today's market capitalisation of Novelix Pharmaceuticals Ltd is ₹98.55 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Novelix Pharmaceuticals Ltd?

Novelix Pharmaceuticals Ltd’s 52 week high is ₹52.79 and 52 week low is ₹20.87. The current share price of Novelix Pharmaceuticals Ltd is ₹41.47, which is -21.44% down from its 52 week high and 98.71% up from its 52 week low.